Skip to main content
. 2017 Oct 6;8(55):93319–93337. doi: 10.18632/oncotarget.21555

Figure 5. Both PRPF8 depletion and PlaB treatment cause a reduction in H3K9Ac and H4K16Ac, and the latter causes a marked reduction in POL2-S2P.

Figure 5

Cells were treated with siRNAs, PlaB, and DRB as in Figure 3, and chromatin was extracted for immunoblotting analysis of H3K9Ac, H4K16Ac, H3K9me3, POL2-S2P, and Actin. Shown are representative immunoblots from this analysis.